Literature DB >> 2479531

Insulin-like growth factor-I (IGF-I) infusion into hypophysectomized or protein-deprived rats induces specific IGF-binding proteins in serum.

D R Clemmons1, J P Thissen, M Maes, J M Ketelslegers, L E Underwood.   

Abstract

The insulin-like growth factors (IGFs) are small peptides that are present in serum and extracellular fluids and stimulate the growth of many cell types. In extracellular fluids the IGFs are bound to carrier proteins that are believed to modify the biological actions of the IGFs. At least three structurally distinct IGF-binding proteins (IGF-BPs) have been identified, and the serum concentrations of one of these has been shown to be regulated by pituitary GH. We report here that this GH responsive protein [39,000-45,000 mol wt (Mr)] can be induced (7-fold) by infusion of IGF-I in hypophysectomized rats or (3.5-fold) in protein-deprived rats, whereas two other forms of IGF-BP (e.g. 31,000-34,000 and 24,000 Mr) showed no change in the hypophysectomized animals and minimal increases in the protein-deprived animals. Likewise, GH injections in hypophysectomized animals resulted in a 7-fold increase in the 39,000-45,000 Mr form and no change in the 31,000-34,000 and 24,000 Mr forms. The protein-deprived animals showed a 3.2-fold increase in the 39,000-45,000 Mr and 2.4- to 1.8-fold increases in the 31,000-34,000 and 24,000 Mr forms, respectively. Changes in the larger Mr IGF-BP in these experimental models are paralleled by changes in serum IGF-I, suggesting that the GH dependence of the former protein is mediated at least partially via IGF-I. Our findings also suggest that the secretion of IGF-I and at least one IGF-BP may be linked, providing a mechanism by which their extracellular fluid concentrations are coordinated. Because IGF-BPs are present in extracellular fluids and can modulate IGF-I-receptor interaction, induction of this protein may be an important mediator of IGF action.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2479531     DOI: 10.1210/endo-125-6-2967

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

Review 1.  Insulin-like growth factors in the peripheral nervous system.

Authors:  Kelli A Sullivan; Bhumsoo Kim; Eva L Feldman
Journal:  Endocrinology       Date:  2008-08-21       Impact factor: 4.736

2.  Effects of constant infusion with insulin-like growth factor-I (IGF-I) to immature female rats on body weight gain, tissue growth, and sexual function : Evidence that such treatment does not affect sexual maturation or fertility.

Authors:  N M Gruaz; V d'Allèves; Y Charnay; A Skotther; S Ekvärn; L Fryklund; M L Aubert
Journal:  Endocrine       Date:  1997-02       Impact factor: 3.633

3.  Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.

Authors:  R Meyer-Schwickerath; A Pfeiffer; W F Blum; H Freyberger; M Klein; C Lösche; R Röllmann; H Schatz
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

4.  Regulation of insulin-like growth factor-I and binding protein-3 expression in oMtla-oGH transgenic mice.

Authors:  J C Chow; J D Murray; D Pomp; R L Baldwin; C C Calvert; A M Oberbauer
Journal:  Transgenic Res       Date:  1994-03       Impact factor: 2.788

Review 5.  Metabolic effects of recombinant human insulin-like growth factor-I in humans: comparison with recombinant human growth hormone.

Authors:  N Mauras; M W Haymond
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

6.  Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously.

Authors:  S R Kupfer; L E Underwood; R C Baxter; D R Clemmons
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

7.  Replicated selection for insulin-like growth factor-1 and body weight in mice.

Authors:  R L Baker; A J Peterson; J J Bass; N C Amyes; B H Breier; P D Gluckman
Journal:  Theor Appl Genet       Date:  1991-05       Impact factor: 5.699

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.